Clinical Trial Update: Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates itraconazole in combination with ablation to prevent progression to esophageal cancer in patients with high-risk Barrett's es…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Adenocarcinoma

Drugs mentioned

• Itraconazole (Sporanox) (Itraconazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Barrett Esophagus, Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Phase 2 | Status: NOT_YET_RECRUITING